| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.33B | 13.95B | 13.44B | 10.78B | 4.80B | 1.64B |
| Gross Profit | 4.15B | 2.65B | 3.88B | 2.22B | 120.70M | -66.90M |
| EBITDA | 4.09B | 3.07B | 3.06B | 2.44B | 381.00M | -337.00M |
| Net Income | 2.24B | 1.61B | 1.92B | 1.31B | -240.80M | -1.02B |
Balance Sheet | ||||||
| Total Assets | 16.04B | 17.51B | 17.18B | 16.41B | 15.15B | 12.33B |
| Cash, Cash Equivalents and Short-Term Investments | 2.42B | 3.96B | 4.11B | 4.66B | 3.60B | 3.12B |
| Total Debt | 1.53B | 2.68B | 2.75B | 4.12B | 5.08B | 5.43B |
| Total Liabilities | 7.26B | 10.47B | 9.56B | 10.76B | 9.60B | 7.68B |
| Stockholders Equity | 8.78B | 7.04B | 7.61B | 5.64B | 5.55B | 4.65B |
Cash Flow | ||||||
| Free Cash Flow | -16.43M | 1.86B | 766.00M | 1.98B | 758.90M | 758.90M |
| Operating Cash Flow | 1.62B | 3.42B | 3.16B | 3.89B | 1.94B | 1.94B |
| Investing Cash Flow | -1.16B | -1.43B | -1.56B | -1.90B | -1.41B | -1.41B |
| Financing Cash Flow | -2.14B | -2.00B | -1.33B | -1.05B | -536.50M | -536.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $14.47B | 10.91 | 135.39% | 3.50% | 6.81% | 58.22% | |
73 Outperform | $31.88B | 269.96 | 27.85% | 1.37% | 14.75% | 71.73% | |
72 Outperform | $44.56B | -37.50 | 23.14% | 0.96% | 4.33% | -1.58% | |
68 Neutral | $31.18B | 10.91 | 24.13% | ― | 4.24% | 20.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | $19.43B | 50.61 | 5.33% | 1.73% | 0.65% | ― | |
46 Neutral | $7.47B | 25.57 | -2.76% | ― | 1.27% | 118.64% |